| Literature DB >> 35562999 |
Carmen Costas-Ferreira1, Rafael Durán1, Lilian R F Faro1.
Abstract
Glyphosate, a non-selective systemic biocide with broad-spectrum activity, is the most widely used herbicide in the world. It can persist in the environment for days or months, and its intensive and large-scale use can constitute a major environmental and health problem. In this systematic review, we investigate the current state of our knowledge related to the effects of this pesticide on the nervous system of various animal species and humans. The information provided indicates that exposure to glyphosate or its commercial formulations induces several neurotoxic effects. It has been shown that exposure to this pesticide during the early stages of life can seriously affect normal cell development by deregulating some of the signaling pathways involved in this process, leading to alterations in differentiation, neuronal growth, and myelination. Glyphosate also seems to exert a significant toxic effect on neurotransmission and to induce oxidative stress, neuroinflammation and mitochondrial dysfunction, processes that lead to neuronal death due to autophagy, necrosis, or apoptosis, as well as the appearance of behavioral and motor disorders. The doses of glyphosate that produce these neurotoxic effects vary widely but are lower than the limits set by regulatory agencies. Although there are important discrepancies between the analyzed findings, it is unequivocal that exposure to glyphosate produces important alterations in the structure and function of the nervous system of humans, rodents, fish, and invertebrates.Entities:
Keywords: fish; glyphosate; glyphosate-based herbicides (GBH); human; neurotoxic effects; rodent
Mesh:
Substances:
Year: 2022 PMID: 35562999 PMCID: PMC9101768 DOI: 10.3390/ijms23094605
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Glyphosate inhibits the enzymatic activity of the 5-endopyruvylshikimate 3-phosphate synthase (EPSPS) in the shikimic acid pathway, preventing the synthesis of the aromatic amino acids tyrosine, phenylalanine, and tryptophan.
Figure 2Flow diagram of the systematic search process.
Studies on the effects of glyphosate and/or its commercial formulations in humans.
| Type of Study | Toxic Agent | Exposure Mode/Objetives | Results | Reference |
|---|---|---|---|---|
| Transversal study | GBH | Occupational exposure |
Positive association between GBH exposure and visual memory impairment | [ |
| Prospective cohort study | GBH | Not specified |
↑ in S100B protein levels in patients with neurological complications S100B protein was a predictor of neurological complications in GLY-poisoned patients | [ |
| Population-based case-control study | GBH | Occupational exposure |
Prenatal and infant exposure increases the risk of autism spectrum disorder Exposure during childhood appears to increase the risk of developing more severely impaired phenotypes with comorbid intellectual disability | [ |
| Cohort study | GBH | Occupational exposure |
GBHs were associated with lower toxicity to farmers’ health compared to other non-GBHs | [ |
| Cohort study | GBH | Occupational exposure |
No relationship was found between GBH use and peripheral nerve conduction abnormalities in farmers | [ |
| In vitro | GLY alone or mixed with other formulants: 5.33 to 3.200 μg/mL for 24 h | Investigate whether GBH toxicity is related to formulants |
Inhibition of cell proliferation when GLY was administered with other formulants but not when it was administered alone | [ |
| In vitro | GLY, AMPA: 0.1 to 1000 μM for 24 or 48 h | Investigate the effect of GLY on the BBB in vitro and compare it with that of AMPA and glycine |
GLY and its metabolite altered the integrity of the BBB GLY can be released through the BBB High doses of GLY and AMPA altered glucose uptake by microvascular endothelial cells in the brain and metabolic activity of neurons | [ |
| In vitro | GLY, AMPA: 0.1 to 20 mM for 48 h | Investigate the effects of GLY and AMPA on oxidative stress, neurodevelopment, and cell death. |
↓ cell viability and increased leakage of LDH ↑ production of MDA, NO, and ROS ↑ caspase-3/7 activity GLY ↑ the levels of mRNA-Wnt3a, -Wnt5a, and -Wnt7a GLY positively regulated IL-6 and TNF-α genes GLY ↑ the expression of CAMK2A and CAMK2B mRNA GLY and AMPA downregulated the expression of the GLY and AMPA altered the gene expression of cell death pathways | [ |
Abbreviations: GBH, glyphosate-based herbicide; ↑, increase; S100B, S100 calcium-binding protein B; GLY, glyphosate; iPSCs, induced pluripotent stem cells; AMPA, aminomethylphosphonic acid; BBB, blood–brain barrier; ↓, decrease; LDH, lactate dehydrogenase; MDA, malondialdehyde; NO, nitric oxide; ROS, reactive oxygen species; IL-6, interleukin-6; TNF-α, tumor necrosis factor alpha; CAMK2, Ca2+/calmodulin-dependent protein kinase 2.
In vivo effects of glyphosate and/or its commercial formulations in rodents.
| Species | Dose and Exposition | Time Exposition | Objectives | Results | Reference |
|---|---|---|---|---|---|
| Swiss mice | Roundup®: 250 or 500 mg/kg/day orally | Subchronic exposition: 6 weeks | Assess the effects of acute or repeated GBH exposure on the developing brain of young and adult mice | Chronic/subchronic exposure: ↓ locomotion ↑ anxiety, depressive behavior ↓ 5-HT immunoreactivity | [ |
| Swiss mice | Roundup®: 250 or 500 mg/kg/day orally | Subchronic exposition: 6 weeks | Evaluate the effects of GBH on learning and memory functions, AChE activity, and oxidation/antioxidation homeostasis | Chronic/subchronic exposure: Impaired recognition and retention memory ↓ AChE activity ↓ SOD and peroxidase activity | [ |
| Swiss mice | Roundup®: 250 or 500 mg/kg/day orally | From GD0 to PND21 | Evaluate the behavioral (PND5-PND25) and biochemical (PND60) effects of gestational and lactational exposure to GBH on offspring |
Delayed sensorimotor development from PND5 to PND25 ↓ locomotion, anxiety, ↓ sociability, cognitive impairment ↓ number of TH+ cells ↓ AChE activity Activation of microglia and astrocytes. ↑ TNF-α expression and ↓ BDNF. ↑ TrkB levels | [ |
| CF-1 mice | Glifloglex®: 50 mg/kg/day intranasally | Three days a week for four weeks | Assess the neurobehavioral effects of repeated intranasal administration of a GBH |
↓ locomotion ↑ anxiety Impaired recognition memory | [ |
| Wistar rats | Roundup®: 70 mg/kg/day orally | Chronic exposition: from GD5 to PND15. | Determine the neurotoxic effects of GBH on the hippocampal function of immature rats after chronic exposure (pregnancy and lactation) and after acute in vitro exposition. | Acute in vitro exposition: ↑ glutamate release, activation of NMDAR and L-VDCC, and ↑ Ca2+ influx CaMKII and ERK activation LPO, ↓ GGT and G6PD activity, ↓ GSH content ↓ cellular viability Impaired glutamate metabolism in astrocytes: ↓ reuptake and metabolism, inhibition of glutamine synthetase ↑ uptake of Ca2+ ↑ accumulation of C-MeAIB | [ |
| Wistar rats | Roundup®: 1% in drinking water (0.38% GLY) | Subchronic exposition: from GD5 to PND21. | Investigate the effects of subchronic exposure to GBH on neurochemical and behavioral parameters in immature and adult offspring |
↓ uptake and ↑ glutamate release Activation of NMDARs and influx of Ca2+ GLY can bind to the glutamate and glycine cavities of NMDAR ↓ AChE activity in offspring Depressive behavior ↓ levels of GSH (acute exposure) ↓ GST after acute exposure, ↑ after chronic exposure ↓ SOD and G6PD activity ERK1/2 overactivation ↓ NF-kB activation ↓ levels of S100B protein during development, which later increased in adult offspring | [ |
| Wistar rats | Roundup®: 70 mg/kg/day orally | Subchronic exposition: from GD5 to PND15. | Investigate possible biochemical and cell-persistent effects in the brain of adult rats following perinatal exposure to GBH |
Changes in the peptide expression in the SN ↓ expression of peptides from the dynorphin family ↓ dynorphin immunoreactivity in the SN and hippocampus ↑ number of nestin-positive hippocampus cells | [ |
| Wistar rats | GLY: 24 or 35 mg/kg intraperitoneally | Dams received injections every 48 h from GD8 to GD20, totaling seven injections over two weeks | Evaluate the neurobehavioral effects of GLY in neonate rats after gestational exposure |
Delay in the development of neonatal reflexes in offspring ↓ locomotion Learning and memory deficits Negative regulation of the Wnt5a/CaMKII pathway | [ |
| Sprague-Dawley rats | GLY, Roundup®: 5 mg/kg/day orally | From GD10 to PND22 | Compare the potential effects of a low dose of GLY and GBH on maternal behavior and maternal neuroplasticity, focusing on the hippocampus and cingulate gyrus |
Initial reduction in maternal licking behavior, followed by a subsequent increase Impairment of neurogenesis and plasticity in the mother’s hippocampus Alteration in synaptophysin expression | [ |
| CF-1 mice | Glifloglex®: 50 mg/kg/day intranasally | Four weeks (three injections per week) | Elucidate the mechanisms by which the intranasal administration of a GBH exerts its neuropathological effects |
↓ total thiol content and CAT activity ↓ expression of ChAT and α7 nAChRs and AChE activity ↑ number of astrocytes ↓ GPT and GOT transaminase activity | [ |
| Sprague-Dawley rats | GLY: 50, 100, or 150 mg/kg intraperitoneally | Two weeks (three injections per week) | Assess the integrity of the nigrostriatal and mesolimbic dopaminergic systems and their relationship with spontaneous locomotor activity after repeated or acute exposure to GLY |
↓ locomotion in the short term ↓ specific binding of an antagonist to dopamine D1 receptors in the short term ↓ levels of extracellular dopamine in the short term | [ |
| ICR mice | Roundup®: 50 mg/kg/day orally | From GD14 to PND7 | Assess the miRNA expression patterns in the PFC of mouse offspring after exposure to GBH during pregnancy and lactation |
Dysregulation of 53 miRNAs involved in brain development and in the pathogenesis of non-destructive diseases | [ |
| Balb/c mice | Roundup®: 25, 50 or 100 mg/kg orally | Acute exposure | Investigate the behavioral effects induced by acute exposure to a GBH in increasing doses |
↓ exploratory capacity of females ↑ immobility time | [ |
| Wistar rats | GBH: 2.5, 5, 10, 20 or 40 mM | Single dose | Assess the inhibitory potency of a GBH on AChE activity in rat tissues |
GBH is a weak inhibitor of AChE activity | [ |
| Wistar rats | GLY: 35 or 70 mg/kg subcutaneous injection | From PND7 to PND27 | Evaluate the effects of glyphosate on hippocampal synapses and cognitive functioning |
Impairment of spatial memory and recognition ↓ expression of CAMKII ↓ expression of synaptic proteins | [ |
| Wistar rats | GLY: 35, 75, 150 or 800 mg/kg/day orally | Six days | Determine the effects of GLY on the levels of DA, NE, and 5-HT and their metabolites, as well as the turnover in striatum, hippocampus, PFC, hypothalamus, and midbrain. |
Significant dose- and region-dependent decreases in 5-HT, DA, and NE contents ↑ turnover of 5-HIAA/5-HT in the striatum and DOPAC+HVA/DA in the PFC and hippocampus ↓ turnover of NE/MHPG in the PFC and hypothalamus | [ |
Abbreviations: GBH, glyphosate-based herbicide; ↓, decrease; ↑, increase; 5-HT, serotonin; TH, tyrosine hydroxylase; AChE, acetylcholinesterase; SOD, superoxide dismutase; GD, gestational day; PND, postnatal day; TNF-α, tumor necrosis factor alpha; BDNF, brain-derived neurotrophic factor; TrkB, tyrosine-related kinase receptor B; NMDAR: N-methyl-D-aspartate receptor; L-VDCC, voltage-dependent calcium channels; CaMKII, Ca2+/calmodulin-dependent protein kinase II; ERK, extracellular signal-regulated kinases; LPO, lipid peroxidation; GGT, gamma-glutamyl transferase; G6PD, glucose-6-phosphate dehydrogenase; GSH, glutathione; C-MeAIB, C-methylaminoisobutyric acid; GLY, glyphosate; GST, glutathione S-transferase; NF-kB, nuclear factor-kB; S100B, S100 calcium-binding protein B; SN, substantia nigra; CAT, catalase; ChAT, choline acetyltransferase; nAChRs, nicotinic acetylcholine receptors; GPT, glutamate-pyruvate transaminase; GOT, glutamate-oxaloacetate transaminase; PFC, prefrontal cortex; DA, dopamine; NE, noradrenaline; 5-HIAA, 5-hydroxyindoleacetic acid; DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanillic acid; MHPG, methoxy-4-hydroxyphenylglycol.
In vitro effects of glyphosate and/or its commercial formulations in rodents.
| Cellular Line | Dose and Time of Exposure | Objectives | Results | Reference |
|---|---|---|---|---|
| PC12 cells | GLY: 0, 5, 10, 20, or 40 mM for 12, 24, 48, or 72 h | Investigate the neurotoxicity of GLY in differentiated rat PC12 cells and explore the role of apoptosis and autophagy pathways in toxicity |
↓ cell viability Activation of autophagic and apoptotic cell death pathways | [ |
| Hippocampal pyramidal cells | GLY: 0.5 or 1 mg/mL for five or ten days | Examine the effects of glyphosate on synapse formation and maturation in the hippocampus |
↓ dendritic complexity and synaptic column formation and maturation ↓ synapse formation in hippocampal neurons | [ |
| NSC | GLY: 0.1, 700, 7000, or 36,000 μg/L for 24 h | Understand the effects of two maximum permissible concentrations of GLY on the basic processes of neurogenesis in NSCs of the postnatal mouse subventricular zone. |
↓ cell viability and induction of cytotoxicity ↓ cell migration and differentiation ↓ expression of neuronal and astrocytic genes ↓ expression of the ↑ expression of the ↑ Ca2+ signaling | [ |
| Astroglioma (C6) | GLY: concentrations from 0 to 160 mM for 24 h | Determine the activity of enzymes related to energy metabolism, as well as parameters of oxidative stress, mitochondrial mass, nuclear area, and autophagy in astrocytes treated with GBH |
↓ cell viability ↓ in the activity of the enzymes of the mitochondrial respiratory chain ↓ CK activity ↓ mitochondrial mass ↑ non-protein thiol levels ↑ autophagic protein levels | [ |
| Embryonic DRG and pure Schwann cells | GLY, Roundup®: 0.0005% and 0.005% for ten days (DRG) or 72 h (Schwann cells) | Investigate the effects of pure GLY and GBH in murine embryonic DRG cultures |
GBH had a demyelinating effect, but this effect was not observed after treatment with GLY GBH ↑ expression of TNF-α in DRG and in Schwann cells GBH ↑ NO release in Schwann cells | [ |
| Embryonic DRG and pure Schwann cells | GLY, Roundup®: doses not specified for ten days (DRG) or 72 h (Schwann cells) | Study and compare the effects of pure GLY and GBH in murine embryonic DRG explant cultures |
GBH had a concentration-dependent demyelinating effect GBH ↑ TNF-α expression and NO release in Schwann cells | [ |
Abbreviations: PC-12, pheochromocytoma; GLY, glyphosate; ↓, decrease; NSC, neural stem cells; ↑, increase; SOD, superoxide dismutase; GBH, glyphosate-based herbicide; CK, creatine kinase; DRG, dorsal root ganglia; TNF-α, tumor necrosis factor alpha; NO, nitric oxide.
Effects of glyphosate and/or its commercial formulations in fish.
| Species | Dose and Time Exposure | Objectives | Results | Reference |
|---|---|---|---|---|
| GLY: 1 or 10 mg/L for 96 h | Assess the effect of seasonal variability on AChE activity in fish exposed to chlorpyrifos and GLY |
↓ AChE activity dose-dependently (all seasons) Fish were more susceptible to GLY in autumn No inhibitory effect on AChE was observed when in vitro tests were performed at a wide range of GLY concentrations | [ | |
| Roundup®: 10 or 15 mg/L for 96 h | Investigate the effects of GBH on gill morphology and function, hematological parameters, biotransformation enzymes, the antioxidant system in the gills and liver, as well as on both neurological and erythrocytic DNA damage |
↓ AChE activity | [ | |
| Roundup®, GLY: 0.01, 0.065, or 0.5 mg/L for 96 h | Evaluate the effects of GLY and GBH on morphological and behavioral parameters in larvae and adult zebrafish | GLY and GBH caused: Alteration of locomotion and aversive behavior in larvae ↓ locomotion and aggressive behavior in adults GBH caused memory impairment in adults | [ | |
| GLY: 5, 10, or 50 μg/mL for 96 h | Identify a possible mechanism of toxicity for GLY related to changes in microtubule stability, which could alter the distribution and dynamics of cytoskeletal components | GLY (50 μg/mL) ↓ levels of acetylated α-tubulin GLY (10 and 50 μg/mL) ↓ percentage of polymeric tubulin | [ | |
| Pintado da Amazônia | Roundup®: 0.37, 0.75, 2.25, 4.5, 7.5, 11.25, 15, 22.5, or 30 mg/L for 24, 48, 72, or 96 h | Evaluate the lethal concentration of the GLY and the oxidative stress parameters in tests with sublethal concentrations |
↑ content of carbonyl protein Brain LPO levels remained unchanged ↑ brain AChE activity | [ |
| GLY: 0.3 or 3 μg/L for 2 weeks | Analyze the neurotoxicity of GLY in adult zebrafish after exposure through water to environmentally relevant concentrations |
Deterioration of exploratory and social behaviors, with increased anxiety ↑ levels of 5-HT in the anterior brain ↑ DA, DOPAC, and HVA in the anterior brain; ↑ DOPAC/DA and HVA/DA turnover Downregulation of the expression of genes involved in the dopaminergic system: ↑ LPO and alteration of brain antioxidant status: ↑CAT and SOD activity and ↓ GSH | [ | |
| GLY: 0.05 to 10.000 μg/L for a period of 1.5 to 120 h after fertilization | Explore the effects of the use of different concentrations of GLY on anatomy and behavior of fish | High concentrations of GLY (≥1000 μg/L) caused: Electrophysiological changes in the midbrain and ↓ locomotion Morphological signs of microglia activation Dysregulation of genetic pathways involved in neuronal physiology, synaptic transmission, and inflammation Absence of neurovascular structural malformations | [ | |
| Roundup®: 0.064, 0.64, 6.4, 64, or 640 mg/L for 6 h | Compare the sublethal toxicity of four herbicides (penoxsulam, imazamox, fluridone, and GBH). |
GBH did not cause alterations in AChE activity | [ | |
| GLY: 0.02, 0.05, 0.07, or 0.1 mg/L for 24, 48, 72, or 96 h | Analyze the effect of GLY and atrazine on the hematological and biochemical parameters of blood and on behavioral aspects |
GLY caused behavioral disturbances | [ | |
| Roundup®: 2, 5, or 8.5 μg/mL for 72 h | Investigate the lethal and sublethal developmental effects, neurotoxic potential, and oxidative stress responses after GBH exposure | High concentrations of GBH caused: Developmental toxicity Malformations Did not have teratogenic effects and did not alter oxidative stress, neurotransmission, or the regulation of energy metabolism Did not cause histopathological changes in the brain | [ | |
| Roundup®: 1, 2, or 5 μg/mL for 72 h | Assess GBH effects at environmentally relevant concentrations through a set of behavioral patterns | Did not alter exploratory or social behavior but did induce changes in avoidance behavior | [ | |
| Nongteshi®: 0.22, 0.44, or 0.88 mmol/L for 96 h | Investigate the toxic effects of GBH exposure using a metabolomic approach supplemented with histological inspection and hematological evaluation |
Destruction of the microscopic structure of the brain High concentrations of GBH caused behavioral disturbances Alteration of the balance of neurotransmitters: ↓ glutamate and GABA levels, ↑ glutamine levels ↓ levels of the glial marker myoinositol and NAA ↓ levels of brain creatine/phosphocreatine | [ | |
|
| Nongteshi®: 0.2 mmol/L for 90 days | Assess GBH toxicity after prolonged exposure | Results in the brain: ↓ choline, phosphocholine, and betaine levels ↑ 3-hydroxybutyrate levels ↓ AMP levels ↓ succinate and citrate Positive correlations between choline and phosphocholine, choline and betaine, glycine, and sarcosine | [ |
| GLY: 5 or 10 mg/L for 24 and 96 h | Evaluate oxidative stress parameters, as well as the activity and expression of AChE | ↓ brain LPO 24 h after exposure to GLY (10 mg/L) No alterations in the generation of ROS No alterations in AChE activity were detected | [ | |
|
| GLY: 1, 17.5, or 35 mg/L for 96 h | Assess the toxic effect of acute exposure to sublethal GLY concentrations on AChE activity in different parts of the body |
↓ AChE activity in the anterior and middle sections of the body but not in the posterior section | [ |
| GBH: 1 or 10 mg/L for 15 days | Determine the basal levels of adenylates, phosphagens, and the AEC index in the brain, muscle, and liver, as well as the impact of exposure to sublethal GBH on the subcellular energy balance |
There was no alteration of cerebral AEC | [ | |
| GBH, GLY: 0.065, 1, 10, 160, 1.6 × 103, 4 × 103, or 8 × 103 mg/L for 3 h (in vitro) or for 7 days (in vivo) | Investigate the neurotoxic effects of GBH by focusing on acute toxicity, activity, and transcription levels of mitochondrial respiratory chain complexes, mitochondrial membrane potential, reactive species formation, and behavioral repertoire | In vivo exposure to GBH (7 days) caused: Modulation of gene expression related to mitochondrial complexes Increased ROS production Mitochondrial hyperpolarization in brain cells Behavioral disturbances Inhibition of NADH dehydrogenase and cytochrome C | [ | |
| Roundup®, GLY: 50 μg/mL for 24 h | Investigate the neurotoxic effects of GBH and GLY exposure on the developing brain | Both GBH and GLY caused: Loss of delineated cerebral ventricles and reductions in the cephalic and ocular regions | [ | |
| Roundup® (Original, Transorb or WG): 0.5 mg/L for 96 h | Evaluate and compare the effects of three GBH formulations on behavior patterns | Roundup WG® was the most harmful formulation and negatively affected: Social interaction Space exploration and swimming performance Long-term memory consolidation | [ | |
| GLY: 6.5 mg/L for 12, 24, 48, or 72 h | Investigate the effects of GLY on the antioxidant system, as well as the neurotoxic effects on eggs and larvae |
↑ AChE activity at 12 and 48 h of treatment, ↓ between 48 and 72 h There were no changes in CAT or GST activity ↑ activity of the GR at 12 and 24 h ↑ LPO at 48 h of treatment | [ | |
| GLY: 0.01, 0.1, 0.5, 1, 5, 10, 100, 200, 400, or 600 mg/L from 3 hpf until 96 hpf | Assess the developmental, morphological, and genetic effects of GLY in zebrafish embryos |
Concentrations of GLY higher than 100 mg/L caused delay and alterations in development, as well as embryonic death Damage to axons of primary caudal motor neurons in embryos and increased locomotion in larvae | [ |
Abbreviations: GLY, glyphosate; ↓, decrease; AChE: acetylcholinesterase; GBH, glyphosate-based herbicide; ↑, increase; LPO, lipid peroxidation; 5-HT, serotonin; DA, dopamine; DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanillic acid; CAT, catalase; SOD, superoxide dismutase; GSH, glutathione; GABA, gamma-aminobutyric acid; NAA, N-acetyl-L-aspartate; AMP, adenosine monophosphate; ROS, reactive oxygen species; AEC, adenylate energy charge; NADH, nicotinamide adenine dinucleotide dehydrogenase; GST, glutathione S-transferase; GR, glutathione reductase; hpf, hours post fertilization.
Figure 3Exposition to glyphosate; its main metabolite, AMPA (aminomethylphosphonic acid); or its commercial formulations induces neurotoxic effects in all studied species. The main modes of action include changes in the development of the nervous system and in the neurotransmission systems, oxidative stress, neuroinflammation, processes that lead to neuronal death, and the appearance of behavioral changes. Changes in the structure and function of neurons lead to the development of neuropathology, encephalopathology, and sensory and motor dysfunctions.
Figure 4Possible mechanism of action of glyphosate or GBH in the nervous system. The presence of glyphosate induces several changes, including (1) opening of nAChRs and NMDA receptors, as well as entry of Na+ and Ca2+ into the cell due to increased levels of ACh and GLU and/or the direct binding of glyphosate to the cavities of NMDAR; (2) opening of the VDCCs by cellular depolarization and entry of Ca2+; (3) activation of the metabotropic GLU and ACh receptors, which stimulate the PLC to generate IP3, which causes the release of Ca2+ from inside the ER; (4) increase in the levels of Wnt-5a, which binds to Frizzled receptors and triggers the generation of IP3, with the consequential release of Ca2+ from the interior of the ER; (5) Ca2+ binding to ryanodine receptors and Ca2+ release from inside the ER; (6) binding of Ca2+ to calmodulin and activation of nNOs, which releases NO; (7) modification of the activity and/or concentrations of endogenous antioxidants; (8) excessive levels of ROS, leading to oxidation of lipids, proteins, and DNA; (9) activation of glial cells, which release inflammatory cytokines and NO; (10) release of S100B protein, which binds to neuronal RAGEs and increases ROS overproduction; (11) activation of ERK due to excessive levels of Ca2+ and ROS, which activates Beclin 1 and induces autophagy; (12) increased levels of Wnt-3a, which binds to Frizzled receptors and induces autophagy; (13) mitochondrial dysfunction, leading to activation of the intrinsic apoptosis pathway; and (14) binding of the ligand TNF-α to the death receptor, activating the extrinsic apoptosis pathway. Parts of the figure were created using templates from Servier Medical Art, which are licensed under a Creative Commons Attribution 3.0 Unported License (http://smart.servier.com/ accessed on 17 February 2022). Abbreviations: GBH: glyphosate-based herbicide; GLU: glutamate; nAChR: nicotinic acetylcholine receptor; NMDAR: N-methyl-D-aspartate receptor; VDCC: voltage-dependent calcium channel; PLC: phospholipase C; IP3: inositol trisphosphate; ER: endoplasmic reticulum; CaM: calmodulin; nNOS: neuronal nitric oxide synthase; NO: nitric oxide; SOD: superoxide dismutase; CAT: catalase; GPx: glutathione peroxidase; PRX: peroxidase; GGT: gamma-glutamyl transferase; G6PD: glucose-6-phosphate dehydrogenase; GST: glutathione S-transferase; GR: glutathione reductase; GSH: glutathione; ROS: reactive oxygen species; IL-6: interleukin-6; TNF-α: tumor necrosis factor alpha; S100B: S100 calcium-binding protein B; RAGE: receptor for advanced glycation end products; ERK: extracellular signal-regulated kinase; ↑, increase; ↓, decrease.